OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-03-31-accounts

THE BRITISH BLOOD TRANSFUSION SOCIETY

(Charitable company limited by guarantee)

REPORT AND UNAUDITED FINANCIAL STATEMENTS

31 MARCH 2023

Registered company number 01723353

Registered charity number 326374

ARMSTRONG WATSON Chartered Accountants Newcastle upon Tyne

THE BRITISH BLOOD TRANSFUSION SOCIETY (Charitable company limited by guarantee)

CONTENTS

Page

THE BRITISH BLOOD TRANSFUSION SOCIETY

REFERENCE AND ADMINISTRATIVE INFORMATION

31 MARCH 2023

Council members Dr H Doughty (resigned 14 September 2022) Dr G D Poole Mrs C E George Dr I Sullivan Mrs L Wong (resigned 31 March 2023) Mr R C Haggas Miss J Staves Mrs R Braund (appointed 14 September 2022) Dr N Osaro (appointed 14 September 2022) Dr D Roberts (appointed 14 September 2022)

Officers

President: Dr G D Poole Treasurer: Mr R C Haggas

Registered company number 01723353 Registered charity number 326374 Website www.bbts.org.uk

Registered office First Floor Administration office Unit 22 One Strawberry Lane Enterprise House Newcastle upon Tyne Manchester Science Park NE1 4BX Lloyd Street North Manchester M15 6SE

Independent examiner

Mr D R Gold Armstrong Watson Audit Limited First Floor One Strawberry Lane Newcastle upon Tyne NE1 4BX

Bankers

HSBC Bank plc 348 Oxford Road Manchester M13 9NG

Solicitors

Hay & Kilner LLP The Lumen St James’ Boulevard Newcastle Helix Newcastle upon Tyne NE4 5BZ

1

THE BRITISH BLOOD TRANSFUSION SOCIETY

REPORT OF THE COUNCIL MEMBERS

FOR THE YEAR ENDED 31 MARCH 2023

The Council members are pleased to present their report, together with the unaudited financial statements of the Society for the year ended 31 March 2023 which are also prepared to meet the requirements for a directors’ report and financial statements for Companies Act purposes.

Reference and administrative information set out on page 1 form part of this report. The financial statements comply with the Charities Act 2011, the Companies Act 2006, the Memorandum and Articles of Association and the Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with FRS102, the Financial Reporting Standard applicable in the UK and Republic of Ireland.

Structure, governance and management

Governing document

The British Blood Transfusion Society was established in May 1983 as a company limited by guarantee governed by its Memorandum and Articles of Association (revised September 2011). It is registered as a charity with the Charity Commission. Every member undertakes to contribute such an amount not exceeding £1, as may be required in the event of the Society being wound up while he is a member or within one year after he ceases to be a member.

Appointment of Council members

The Council members consist of officers, elected members and Past President or President Elect. Officers consist of the President of the Society who holds office for two years and the Secretary and Treasurer who hold office for three years. The President can remain as a Council member for a further year after retirement from the office of President. The Secretary and Treasurer are eligible for reappointment by Council, but neither can serve more than six consecutive years in office.

The elected Council members shall be those members of the Council who are not officers and shall each hold office for a period of three years; so far as possible they shall be made up of a mix of professional categories and be representative of the current membership; the period of office may be extended from time to time by the President for a year with a maximum of three extensions providing a maximum term of six years.

The Council members of the charitable company (excluding co-opted members) are its directors for the purposes of company law and trustees for the purposes of charity law. The elected Council members hold office for a period of three years.

Calls for nominations for officers and elected members of Council are made in the BBTS Bloodlines Newsletter and also on the Society’s website. Nominees must be UK members and must have been a member of the Society for a minimum of two years. Nominations must be proposed and seconded by two Society members. Details of the nominees are then published on the ballot papers.

Induction and training of Council members

All new Council members are given an induction pack containing information, links and paperwork about the roles and responsibilities of trustees published by the Charity Commission. They also receive past Council meeting papers and dates of forthcoming Council meetings.

At the first meeting of the new Council, new members are introduced to individual Council members and specific areas of responsibility for new members are discussed and agreed. The Society’s office then provides all the necessary background information and paperwork for new Council members’ individual areas of responsibility .

2

THE BRITISH BLOOD TRANSFUSION SOCIETY

REPORT OF THE COUNCIL MEMBERS

FOR THE YEAR ENDED 31 MARCH 2023

Organisation

The Society is managed by the Council members, who are responsible for the strategic direction and overview of the work of the Society. The Council members must number at least eight and not more than fourteen, all of whom must be members of the Society. Three Council members (including at least one officer) are needed for a quorum.

There are committees and sub-committees of Council members that may co-opt members who are not members of the Council or Society. Co-opted members may not exceed three-quarters of the total number of such committees. These committees include the Executive Working Committee, the Scientific Meetings Administration Committee, the Communications Committee and the Professional Affairs & Education Committee.

The day to day operations of the charity are managed by the BBTS Executive Manager and a small team of staff from an office based in Manchester.

BBTS Enterprises Limited

The charity’s wholly-owned subsidiary was incorporated in May 2003 and carries out trading activities for the charity. The subsidiary gift aids profits to the charity, subject to the retention of reserves for its own working capital requirements.

Risk management

The members of the Council are responsible for overseeing the risks faced by the Society. Within this process, detailed consideration of risks is delegated to the Executive Manager. Risks are identified, assessed and controls established throughout the year. Risks are held in a risk register. Council conducts ongoing reviews of the major risks to which the Society is exposed.

Objectives and activities

The main aim of the Society is to advance for the public benefit, the study of blood transfusion including immunohaematology and to promote research and development into all aspects of blood transfusion practice.

The objectives of the Society continue to be to:

The Council sets itself annual objectives, in furtherance of the above main objectives of the Society. Each objective has a performance measure and responsibility is allocated to a Council member or Council sub-committee. Performance against the annual objectives is reviewed at Council meetings throughout the year and a progress report published in the Annual Review for members to view.

The Council confirm that they have been given the general guidance produced by the Charity Commission on public benefit including the guidance ‘public benefit running a charity (PB2)’. The Council are confident that public benefit is achieved through the study of blood transfusion and development.

3

THE BRITISH BLOOD TRANSFUSION SOCIETY

REPORT OF THE COUNCIL MEMBERS

FOR THE YEAR ENDED 31 MARCH 2023

Achievements and performance

The Society’s charitable activities focus on the study of blood transfusion and are undertaken to further its charitable purposes for the public benefit as described in the following paragraphs:

During the year, Council achieved many of its major objectives including the improvement of our online course delivery and online exams, maintaining a strong Transfusion Medicine impact factor and gaining a respectable financial return from this journal.

The Society worked hard to rewrite its CTP course content, we are planning to relaunch the course next year. We provided three educational webinars. The Transfusion Practitioners group has now formed into a Special Interest Group. We continued to mitigate financial risk to the Society during this period whilst remaining almost entirely financially independent.

Membership of the Society has changed during the year as follows:

Number of members on 1 April 2022
Number of new members
Number of members who left
Number of members on 31 March 2023		 1,618
152
(280)
1,490

4

THE BRITISH BLOOD TRANSFUSION SOCIETY

REPORT OF THE COUNCIL MEMBERS

FOR THE YEAR ENDED 31 MARCH 2023

Financial review

The principal funding sources of the Society are from training income and membership subscriptions. Income from these sources is shown in note 5 to the financial statements.

The net movement in funds for the year was a surplus of £14,539 (2022: £57,751), as shown in the statement of financial activities. There was a gift aid donation of £nil (2022: £nil) from the subsidiary this year, so the operational surplus was £14,539 (2022: surplus of £57,751). The group surplus for the year was £19,085 (2022: surplus £75,743).

Reserves policy

Council has established a policy whereby the unrestricted funds not committed, designated or invested in tangible fixed assets (the free reserves) held by the group should equate to at least £400,000. The reserves are needed to meet the ongoing working capital requirements of the group, to bridge any funding gaps during the development of new activities and to enable the group to continue its current activities in the event of a significant drop in income.

The free reserves of the charity as at 31 March 2023 were £403,196 (2022: £410,734) and those of the trading subsidiary add a further £94,606 (2022: £90,060), a total of £497,802 (2022: £500,794).

Investment powers and policy

Under the Memorandum and Articles of Association, the Society has the power to make investments as the Council members see fit.

Having regard to the Society’s liquidity requirements and reserves policy, Council have, in recent years, operated a policy of keeping available funds in interest-bearing deposit accounts.

Plans for future periods

The Council has set itself a number of annual objectives for 2023/24, in furtherance of the main objectives of the Society. These objectives include the following:

5

THE BRITISH BLOOD TRANSFUSION SOCIETY

REPORT OF THE COUNCIL MEMBERS

FOR THE YEAR ENDED 31 MARCH 2023

Statement of the Council members’ responsibilities in relation to the financial statements

The Council members (who are also directors of the Society for the purposes of company law) are responsible for preparing the report of the Council members and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the Council members to prepare financial statements for each financial year, which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing these financial statements, the Council members are required to:

The Council members are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Small company provisions

This report has been prepared in accordance with the special provisions for small companies under Part 15 of the Companies Act 2006.

On behalf of Council

Dr G D Poole President

8 September 2023

6

INDEPENDENT EXAMINER’S REPORT

TO THE MEMBERS AND COUNCIL MEMBERS OF

THE BRITISH BLOOD TRANSFUSION SOCIETY

I report to the Council members on my examination of the financial statements of the company for the year ended 31 March 2023, which are set out on pages 8 to 16.

Responsibilities and basis of report

As the Council members of the company (and also its directors for the purposes of company law) you are responsible for the preparation of the financial statements in accordance with the requirements of the Companies Act 2006 (‘the 2006 Act’).

Having satisfied myself that the accounts of the company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity’s financial statements as carried out under section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the directions given by the Charity Commission under section 145(5) (b) of the 2011 Act.

Independent examiner’s statement

Since the company’s gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of the Institute of Chartered Accountants in England and Wales, which is one of the listed bodies.

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

  1. accounting records were not kept in respect of the company as required by section 386 of the 2006 Act; or

  2. the financial statements do not accord with those records; or

  3. the financial statements do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a ‘true and fair view which is not a matter considered as part of an independent examination; or

  4. the financial statements have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to Charities preparing their financial statements in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)).

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

D R Gold BA FCA Independent Examiner Armstrong Watson LLP One Strawberry Lane Newcastle Upon Tyne NE1 4BX

8 September 2023

7

THE BRITISH BLOOD TRANSFUSION SOCIETY

STATEMENT OF FINANCIAL ACTIVITIES

(INCLUDING INCOME AND EXPENDITURE ACCOUNT)

FOR THE YEAR ENDED 31 MARCH 2023

Unrestricted Restricted
Note
funds
funds
£
£
Income from:
Donations
4
-
38,000
Charitable activities
5
262,241
-
Investments
6
4,716
-
Total
266,957
38,000
Expenditure on:
Charitable activities
7
252,418
38,000
Net income and movement in funds
14,539
-
Reconciliation of funds:
Total funds brought forward
435,583
-
Total funds carried forward
450,122
-		 Total
2023
£
38,000
262,241
4,716
304,957
290,418
14,539
435,583
450,122		 Total
2022
£
38,032
254,657
197
292,886
235,135
57,751
377,832

435,583

The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure was derived from continuing activities.

The notes on pages 10 to 16 form part of these financial statements.

8

THE BRITISH BLOOD TRANSFUSION SOCIETY

BALANCE SHEET

AS AT 31 MARCH 2023

Note
Fixed assets
Intangible assets
9
Tangible assets
10
Investments
11
Current assets
Debtors
12
Cash at bank
Creditors:amounts falling due within
one year
13
Capital grant
Net current assets
Net assets
Funds of the charity
Unrestricted funds
15
Restricted funds
16
Total charity funds		 2023
£
44,956
1,969
1
46,926
100,972
478,541
579,513
(169,985)
(6,332)
403,196
450,122
450,122
-
450,122		 2022
£
23,356
1,492
1
24,849
141,908
440,527
582,435
(165,369)
(6,332)
410,734
435,583
435,583
-
435,583

For the year ended 31 March 2023 the charity was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Council members’ responsibilities:

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Council members and authorised for issue on 8 September 2023 are signed on their behalf by:

Dr G D Poole

President

Mr R C Haggas Treasurer

Company number 01723353

The notes on pages 10 to 16 form part of these financial statements.

9

THE BRITISH BLOOD TRANSFUSION SOCIETY

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2023

1. Legal status of the charity

The Society is a company limited by guarantee and has no share capital. The liability of each member in the event of winding up is limited to £1.

2. Accounting policies

The principal accounting policies adopted, judgements and key sources of estimation uncertainty in the preparation of the financial statements are as follows:

a) Basis of preparation

The financial statements have been prepared under the historical cost convention with items recognised at cost. They have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities, preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) - (Charities SORP (FRS102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) and the Companies Act 2006.

The financial statements are prepared in sterling which is the functional and presentation currency of the charity.

The British Blood Transfusion Society meets the definition of a public benefit entity under FRS102.

b) Preparation of the accounts on a going concern basis

There is a reasonable expectation that the Society has adequate resources to continue in operational existence for at least the next twelve months and on this basis the Society is considered to be a going concern.

c) Fund structure

i) Restricted funds

General fund

The general fund is credited with subscriptions received from members and income from conferences and meetings. It is charged with the charitable expenditure and governance costs of the Society.

Designated funds

Designated funds comprise unrestricted funds set aside at the discretion of the Council members for particular purposes. The purpose of each designated fund is set out in the notes to the financial statements.

d) Subsidiary undertaking

The investment is included in the financial statements at cost. The financial statements for the Society include only the individual parent charity and are not consolidated to include the trading subsidiary. The parent charity is not required to prepare consolidated financial statements under section 399 of the Companies Act 2006 and is excepted by section 139(2) of the Charities Act 2011 from the requirement to prepare group accounts.

e) Amortisation

Amortisation is calculated so as to write off the cost of the asset, less its estimated residual value, over the useful life of that asset as follows:

Website costs

straight line over 5 years

If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.

10

THE BRITISH BLOOD TRANSFUSION SOCIETY

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2023

2. Accounting policies (continued)

f) Fixed assets and depreciation

Tangible fixed assets are included in the financial statements at their historical cost. Depreciation is provided on all tangible fixed assets at rates calculated to write off the cost less estimated residual value of the assets over their expected useful lives. The rates used are as follows:

Computer equipment - 25% on straight line basis Furniture and fittings - 20% on straight line basis

g) Investment income

Interest is recognised in the statement of financial activities when receivable.

h) Incoming recognition

All income is included in the statement of financial activities when the charity is entitled to the income and the amount can be quantified with reasonable accuracy. The following specific policies are applied to particular categories of income:

Donations are received by way of grants and donations and are included in full in the statement of financial activities when receivable. Such income is only deferred when the donor specifies that the grant or donation must only be used in future accounting periods, or the donor has imposed conditions which must be met before the Society has unconditional entitlement. Specified donations and grants are included within restricted funds when receivable.

Investment income such as interest and gift aid are included when receivable.

Income from charitable activities includes income from membership subscriptions and training and are recognised in the period in which the Society is entitled to receipt. Deferred income represents amounts received for future periods and is released to the statement of financial activities in the period for which it has been received.

i) Expenditure recognition

Expenditure is included in the statement of financial activities on an accruals basis. Grants payable are charged in the year when the payment is made.

Charitable expenditure comprises all costs of activities in furtherance of the objects of the charity.

Governance costs include those costs incurred in the governance of the charity and compliance with constitutional and statutory requirements.

Support costs comprise staff costs and office overheads which are allocated on the basis of staff time spent on each activity for staff costs and on a basis to reflect the use of the resource for office overheads. These are shown in note 7 to the accounts.

j) Cash at bank

Cash at bank includes a current account and an instant access COIF Charities Deposit Fund account.

k) Creditors and provisions

Creditors and provisions are required where the charity has a present obligation resulting from a past event that will probably result in a transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount.

11

THE BRITISH BLOOD TRANSFUSION SOCIETY

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2023

2. Accounting policies (continued)

l) Financial instruments

The Society only has financial instruments and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are measured at a transaction value and subsequently measured at their settlement value.

m) Judgements and key sources of estimation uncertainty

Due to the inherent subjectivity involved in making such judgements, estimates and assumptions, the actual results and outcomes may differ. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised, if the revision affects only that period, or in the period of the revision and future periods, if the revision affects both current and future periods.

3. Net income

Net income for the year is stated after charging:

Independent examination and accounting services:
Independent examination
Accountancy services
Depreciation of tangible fixed assets
4.
Donations
Unrestricted
funds
£
Restricted
funds
£
Donations
Grants
-
-
-
38,000
-
38,000		 2023
£
1,170
7,744
1,130
Total
2023
£
-
38,000
38,000		 2022
£
1,060
7,471
783
Total
2022
£
32
38,000
38,032

5. Charitable activities

Charitable activities Unrestricted Unrestricted

funds
funds
2023 2022
£ £
Membership subscriptions 115,109 122,057
Training 147,131 132,600
262,241 254,657

12

THE BRITISH BLOOD TRANSFUSION SOCIETY

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2023

6.
Investment income
2023
Bank interest
4,716
7.
Total resources expended
Charitable Governance
Total
activities
costs
2023
£
£
£
Direct costs
Meetings and conferences
Publicity
Bursaries and awards
Educational programme
Modernising Scientific Careers
Allocated support costs
Staff costs
Office costs
Depreciation
Accountancy
780
6,254
97
81,624
22,498
97,794
40,727
791
4,143
334
-
-
-
-
12,812
17,454
339
4,144
1,114
6,254
97
81,624
22,498
110,606
58,181
1,130
8,287
Legal and professional fees
439
188
627
255,147
35,271
290,418
8.
Staff costs and numbers
2023
£
Wages and salaries
139,638
National insurance costs
9,017
Pension costs
6,132
154,787
Average number of employees in the year
5		 2022
197
Total
2022
£
676
11,111
100
63,961
20,506
89,862
39,565
783
8,123
448
235,135
2022
£
103,830
8,717
5,066
117,613
4

The Society considers its key management personnel to be the Council members, the executive director and the senior education officer. The total employment benefits of key management personnel were £90,574 (2022: £92,504). There are no employees with emoluments above £60,000 per annum.

No Council members, or any person related or connected by business to them, received any remuneration. During the year 2 (2022: 1) Council members were paid £164 (2022: £186) as reimbursement for expenses of attending meetings.

13

THE BRITISH BLOOD TRANSFUSION SOCIETY

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2023

9.
Intangible assets
Cost
At 1 April 2022
Additions
At 31 March 2023
Amortisation
At 1 April 2022 and 31 March 2023
Carrying amount
At 31 March 2023
At 31 March 2022
10. Tangible fixed assets
Furniture Computer
and fittings equipment
£
£
Cost
At 1 April 2022 9,122 5,326
Additions
-
1,605
At 31 March 2023
9,122
6,930

Depreciation
At 1 April 2022
9,034
3,919
Provided this year
57
1,073
At 31 March 2023
9,091
4,992
Net book value
At 31 March 2023
31
1,938
At 1 April 2022 88
1,406		 9.
Intangible assets
Cost
At 1 April 2022
Additions
At 31 March 2023
Amortisation
At 1 April 2022 and 31 March 2023
Carrying amount
At 31 March 2023
At 31 March 2022
10. Tangible fixed assets
Furniture Computer
and fittings equipment
£
£
Cost
At 1 April 2022 9,122 5,326
Additions
-
1,605
At 31 March 2023
9,122
6,930

Depreciation
At 1 April 2022
9,034
3,919
Provided this year
57
1,073
At 31 March 2023
9,091
4,992
Net book value
At 31 March 2023
31
1,938
At 1 April 2022 88
1,406		 Website
£
23,356
21,600
44,956
-
44,956
23,356
Total
£
14,447
1,605
16,052
12,953
1,130
14,083
1,969
1,494
9,122
6,930
9,034
3,919
57
1,073
9,091
4,992
31
1,938
88
1,406

14

THE BRITISH BLOOD TRANSFUSION SOCIETY

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2023

11. Investments

Investments
2022 2021
£ £
Investment in subsidiary undertaking at cost 1 1

The Society owns 100% of the issued ordinary share capital of BBTS Enterprises Limited, a company registered in England (company number 4775642).

A summary of the results of BBTS Enterprises Limited for the year ended 31 March 2022 and its financial position as at 31 March 2023, were as follows:

Turnover
Expenditure
Profit for the financial year and retained profit
Aggregate capital and reserves/aggregate assets and liabilities

12. Debtors
Other debtors
Amounts due from subsidiary undertaking
Prepayments and accrued income

13. Creditors: amounts falling due within one year
Other creditors
Social security and other taxes
Accruals
Deferred income (note 14)

14. Deferred income
Balance at 1 April 2022

Subscriptions and exam fees received

Released to statement of financial activities

Balance at 31 March 2023		 2023
£
381,203
(376,657)
4,546
104,606
2023
£
20,490
66,989
13,493
100,972
2023
£
12,490
4,829
16,236
136,430
169,985
2023
£
134,876
136,430
(134,876)
136,430
 2022
£
201,495
(183,503)
17,992
100,060
2022
£
24,829
55,199
61,880
141,908
2022
£
13,769
-
16,724
134,876
165,369
2022
£
124,847
134,876
(124,847)
134,876

15

THE BRITISH BLOOD TRANSFUSION SOCIETY

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2023

15. Unrestricted funds
 Balance at Balance at
1 April 31 March
2022 Income Expenditure 2023
£ £
£		 £
General fund 435,583 266,957 (252,418) 450,122
16. Restricted funds Balance at Balance at
1 April 31 March
2022 Income Expenditure
2023
£ £ £ £
Educational programme fund - 38,000 (38,000) -

The educational programme fund comprises grants received to further education and professional development.

17. Analysis of net assets between funds

Intangible Net
fixed Fixed current
assets assets Investments
assets		 Total
£
£		 £ £ £
Unrestricted funds:
General fund 44,956 1,969 1 403,196 450,122
Restricted fund:
Educational programme fund - - - - -
44,956 1,969 1 403,196 450,122

18. Limited liability

The Society is a company limited by guarantee and every member undertakes to contribute such an amount not exceeding £1, as may be required in the event of the Society being wound up while he is a member or within one year after he ceases to be a member for payment of the debts and liabilities of the Society and for the cost of winding up.

16

THE BRITISH BLOOD TRANSFUSION SOCIETY

MANAGEMENT INFORMATION

FOR THE YEAR ENDED 31 MARCH 2023

The following pages do not form part of the statutory financial statements which are the subject of the independent examiner’s report on page 7.

17

THE BRITISH BLOOD TRANSFUSION SOCIETY

SUMMARY INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 31 MARCH 2023

Income
Core activities
Modernising Scientific Careers
Expenditure
Core activities
Modernising Scientific Careers

Core activities
Modernising Scientific Careers
Surplus for the year
 2023
£
294,956
10,000
304,956

256,973
33,444
290,417
37,983
(23,444)
14,539		 2022
£
282,886
10,000
292,886
206,128
29,007
235,135
76,758
(19,007)
57,751

18

THE BRITISH BLOOD TRANSFUSION SOCIETY

INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 31 MARCH 2023

Income
Membership subscriptions
Training
Educational programme grant
Donations and legacies
Interest receivable

Expenditure
Educational programme
Bursaries and awards
Council expenditure
Publicity
Staff costs
Staff recruitment
Staff training
Rent and rates
Light and heat
Insurance
Repairs and maintenance
Software and computer costs
Other travelling expenses
Telephone
Equipment leasing charges
Postage, printing and stationery
Miscellaneous
Recharge of office overheads to MSC
Subscriptions
Accountancy
Legal and professional fees
Depreciation
Bank and credit card charges

Surplus before MSC

Modernising Scientific Careers (MSC) deficit(Page 20)

Surplus for the year
 2023
£
115,109
147,131
28,000
-
4,716
294,956
95,872
97
1,115
6,254
85,412
9,360
-
28,117
1,559
1,266
420
3,706
369
4,177
1,022
3,942
661
(2,957)
3,418
8,287
627
1,130
3,119
256,973

37,983

(23,444)

14,539		 2022
£
122,057
132,600
28,000
32
197
282,886
75,073
100
676
7,703
70,214
-
192
24,443
745
1,044
270
6,900
-
3,703
1,051
2,660
320
(2,790)
2,827
8,123
448
783
1,643
206,128
76,758
(19,007)
57,751

19

THE BRITISH BLOOD TRANSFUSION SOCIETY

MODERNISING SCIENTIFIC CAREERS

INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 31 MARCH 2023


Income
Modernising Scientific Careers grant
Expenditure
Staff costs
Staff secondment costs
Meeting costs
Computer maintenance
Recharge of office overheads

Deficit for the year		 2023
£
10,000

10,946
17,788

776
977
2,957
33,444
(23,444)
 2022
£
10,000
8,536
16,217
817
647
2,790
29,007
(19,007)

20